Jeena Sikho Lifecare Limited (NSE:JSLL)
India · Delayed Price · Currency is INR 512.00
-7.60 (-1.46%)
At close: Sep 11, 2026
Jeena Sikho Lifecare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 8,515 | 8,014 | 4,691 | 3,244 | 2,039 | 1,466 |
| 8,515 | 8,014 | 4,691 | 3,244 | 2,039 | 1,466 | |
Revenue Growth | 58.77% | 70.84% | 44.59% | 59.10% | 39.13% | 7.91% |
Cost of Revenue | 988.64 | 966.23 | 590.49 | 262.67 | 169.4 | 151.92 |
Gross Profit | 7,526 | 7,047 | 4,100 | 2,981 | 1,870 | 1,314 |
Selling, General & Admin | 1,626 | 2,277 | 1,684 | 1,262 | 790.95 | 705.59 |
Other Operating Expenses | 2,273 | 1,271 | 1,011 | 786.41 | 615.08 | 425.46 |
Operating Expenses | 4,433 | 4,025 | 2,985 | 2,100 | 1,437 | 1,164 |
Operating Income | 3,093 | 3,023 | 1,115 | 881.75 | 432.25 | 149.47 |
Interest Expense | -146.47 | -127.49 | -101.83 | -0.71 | -5.47 | -11.11 |
Interest & Investment Income | - | 24.28 | 27.17 | 31.43 | 16.03 | 2.23 |
Other Non Operating Income (Expenses) | 217.54 | 59.25 | 2.03 | -2.63 | -2.93 | 2.37 |
EBT Excluding Unusual Items | 3,164 | 2,979 | 1,042 | 909.85 | 439.89 | 142.96 |
Gain (Loss) on Sale of Investments | - | 0.59 | 10.1 | 6.65 | - | - |
Gain (Loss) on Sale of Assets | - | -2.16 | 23.34 | 11.52 | 5.41 | 7.97 |
Asset Writedown | - | -3.43 | - | - | - | - |
Other Unusual Items | - | - | - | 11.16 | - | - |
Pretax Income | 3,164 | 2,974 | 1,076 | 939.17 | 445.3 | 150.93 |
Income Tax Expense | 800.97 | 756.95 | 276.34 | 247.11 | 107.86 | 38.99 |
Earnings From Continuing Operations | 2,363 | 2,217 | 799.43 | 692.06 | 337.44 | 111.94 |
Minority Interest in Earnings | 1.88 | 1.53 | - | - | - | 0.39 |
Net Income | 2,365 | 2,219 | 799.43 | 692.06 | 337.44 | 112.32 |
Preferred Dividends & Other Adjustments | - | 1.53 | - | - | - | - |
Net Income to Common | 2,365 | 2,217 | 799.43 | 692.06 | 337.44 | 112.32 |
Net Income Growth | 99.45% | 177.32% | 15.51% | 105.09% | 200.42% | 10.60% |
Shares Outstanding (Basic) | 124 | 124 | 124 | 124 | 123 | 91 |
Shares Outstanding (Diluted) | 125 | 124 | 124 | 124 | 123 | 91 |
Shares Change | 0.22% | 0.04% | 0.10% | 0.87% | 35.45% | 0.09% |
EPS (Basic) | 19.02 | 17.84 | 6.43 | 5.57 | 2.74 | 1.23 |
EPS (Diluted) | 18.98 | 17.81 | 6.42 | 5.57 | 2.74 | 1.23 |
EPS Growth | 99.02% | 177.41% | 15.31% | 103.35% | 121.81% | 10.54% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 2,197 | 421.69 | 211.51 | -220.26 | -56.77 |
Free Cash Flow Per Share | - | 17.65 | 3.39 | 1.70 | -1.79 | -0.62 |
Dividend Per Share | - | 4.500 | 1.100 | 0.836 | 0.222 | - |
Dividend Growth | - | 309.09% | 31.58% | 276.24% | - | - |
Gross Margin | 88.39% | 87.94% | 87.41% | 91.90% | 91.69% | 89.63% |
Operating Margin | 36.33% | 37.72% | 23.77% | 27.18% | 21.20% | 10.20% |
Profit Margin | 27.78% | 27.66% | 17.04% | 21.33% | 16.55% | 7.66% |
Free Cash Flow Margin | - | 27.41% | 8.99% | 6.52% | -10.80% | -3.87% |
EBITDA | 3,671 | 3,195 | 1,192 | 932.3 | 462.72 | 181.43 |
EBITDA Margin | 43.12% | 39.87% | 25.41% | 28.74% | 22.69% | 12.38% |
D&A For EBITDA | 578.22 | 171.86 | 77.14 | 50.55 | 30.47 | 31.96 |
EBIT | 3,093 | 3,023 | 1,115 | 881.75 | 432.25 | 149.47 |
EBIT Margin | 36.33% | 37.72% | 23.77% | 27.18% | 21.20% | 10.20% |
Effective Tax Rate | 25.31% | 25.45% | 25.69% | 26.31% | 24.22% | 25.83% |
Revenue as Reported | 8,732 | 8,099 | 4,758 | 3,308 | 2,062 | 1,480 |
Advertising Expenses | - | 626.97 | 580.12 | 428.8 | 298.12 | 349.66 |